Skip to main content
OpenTrials
Completed

NCT Number: NCT02242162

Establishment of a Non-invasive and Indirect Measure of Volitional Pimax

Respiratory failure is the main death cause in muscular diseases. Non-invasive and volitional measures of inspiratory muscles strength include the nasal pressure with an occluded nostril and the maximal inspiratory pressure (PImax).Unfortunately, volitional maneuvers depend of patient effort. The mean of this reseach is to validate a non-invasive and non-volitional technique to evaluate diaphragm strength at muscular diseases patients.The methdology consist to compar PImax measure to nerves magnetical stimulation maneuvers measure.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hopital R Poincaré

Garches, 92380, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Neuromuscular disease
  • Pimax evaluation indication

Exclusion criteria

  • pregnant women
  • usual contre-indications for nuclear magnetic resonance

Treatment and study plan

phrenic nerves magnetic stimulations

Procedure

Primary outcomes

  1. magnetic stimulation pressure measure( Pstim)

    Time frame: 10 minutes

    phrenic nerves magnetic stimulations

Sponsors and collaborators

Lead sponsor

Centre d'Investigation Clinique et Technologique 805

Other

Registry information

Acronym: PI MAX STIM

Important dates

Study start
2009
Primary completion
2016
Study completion
2016
First posted
Sep 16, 2014
Registry last updated
Mar 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.